🩸 Paid Hemophilia Clinical Trials
Browse recruiting hemophilia clinical trials across the United States. Find eligibility information, locations and research opportunities near you.
Browse recruiting hemophilia clinical trials across the United States. Find eligibility information, locations and research opportunities near you.
Showing live studies from ClinicalTrials.gov. Data refreshes daily.
Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.
Hemophilia is a rare bleeding disorder where blood does not clot properly due to deficient clotting factors. Clinical trials investigate gene therapies, extended half-life factor concentrates, and novel non-factor therapies for bleeding prevention.
Excessive bleeding from cuts or injuries, large or deep bruises, joint pain and swelling, unexplained nosebleeds, blood in urine or stool, prolonged bleeding after procedures
Family history, male gender (X-linked inheritance), genetic mutation in factor VIII or IX genes, family history of bleeding disorders
Treatment includes replacement clotting factor concentrates (factor VIII for hemophilia A, factor IX for hemophilia B), desmopressin, and antifibrinolytic medications. Clinical trials explore AAV-based gene therapies, bispecific antibodies (emicizumab), and RNA interference therapies.
Hemophilia clinical trials are pioneering gene therapy approaches that can provide long-term or permanent correction of the clotting defect.